Delivery Order SPE2DB20D2104-SPE2DB25FMSTZ

Award Date 6/6/25
Potential Completion Date 6/9/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,852.50 firm-fixed-price delivery order is for the supply of the prescription medication LO LOESTRIN FE 1-10 TABLET 28S, with a period of performance through May 7, 2025. The contract is not set aside for any particular business size or socioeconomic category. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is a $5,149.80 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the pharmaceutical product "LO LOESTRIN FE 1-10 TABLET 28S" and has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,553.96 firm fixed-price delivery order is for the medical product "LO LOESTRIN FE 1-10 TABLET 28S" and has an ultimate completion date of July 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,757.64, is a delivery order for the pharmaceutical product LO LOESTRIN FE 140S. The contract is a firm fixed-price agreement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $3,163.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the medical product "LO LOESTRIN FE 1-10 TABLET 28S" and has an ultimate completion date of March 24, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract award, valued at $13,069.60, is for the delivery of the medication LO LOESTRIN FE 140S. The contract has an ultimate completion date of March 24, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $2,987.22 and covers the delivery of the medication LO LOESTRIN FE 1-10 TABLET 28S. The contract has a performance period through June 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a firm fixed-price, Ceiling Value of $4,388.56, is for the delivery of Lo Loestrin Fe 1-10 Tablet 28s. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LO LOESTRIN FE 1-10 TABLET 28S. The award has a ceiling value of $1,162.01 and a completion date of June 4, 2025. The contract is a Firm Fixed Price instrument and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Medical Supply Chain division of the Defense agency to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,072.81 firm fixed-price delivery order is for the supply of 4564703881 - LO LOESTRIN FE 1-10 TABLET 28S, with a period of performance through May 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMSTZ
    Delivery Order

This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,612.92 firm-fixed-price contract is for the delivery of the medication LO LOESTRIN FE 1-10 TABLET 28S, with a performance period ending on June 9, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract is not set-aside and represents open competition.

Generated 9/5/25, 9:45 AM